AXA Framlington Biotech Fund R Accumulation GBP/ GB0031007254 /
| NAV11/8/2024 | Chg.+0.0090 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2.8280GBP | +0.32% | reinvestment | Equity Worldwide | AXA IM (UK) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2001 | - | - | - | - | - | - | - | - | - | - | - | 3.73 | - |
| 2002 | -15.44 | -7.33 | 2.46 | -19.31 | -5.96 | -15.44 | -5.42 | -1.18 | -11.39 | 10.49 | 11.19 | -10.58 | -53.12% |
| 2003 | -2.54 | -6.97 | 5.99 | 10.44 | 15.27 | 2.83 | 8.29 | 5.37 | -0.24 | 0.09 | -2.63 | 3.14 | +43.93% |
| 2004 | 8.46 | -2.58 | 0.58 | 6.87 | -11.36 | -2.72 | -12.77 | 5.24 | 6.53 | -0.83 | 0.67 | 6.33 | +1.67% |
| 2005 | -3.98 | -1.87 | -10.01 | -3.71 | 12.39 | 5.54 | 14.03 | -3.06 | 2.54 | -7.44 | 4.09 | 4.10 | +10.12% |
| 2006 | 6.25 | 7.39 | -0.69 | -7.99 | -12.12 | -0.59 | -3.31 | 3.92 | 0.09 | 6.08 | 2.52 | 0.85 | +0.46% |
| 2007 | 1.95 | -2.60 | 0.03 | 8.99 | -1.62 | -7.24 | -5.23 | -0.98 | 4.26 | 1.51 | -4.77 | 2.90 | -3.87% |
| 2008 | -6.45 | -0.42 | -2.51 | 2.57 | 2.39 | -2.63 | 14.00 | 8.24 | -8.47 | -2.63 | -0.72 | 13.85 | +15.45% |
| 2009 | 4.02 | -4.55 | 1.15 | -1.00 | -10.15 | 9.22 | 5.67 | 0.05 | 4.68 | -10.47 | 2.80 | 4.29 | +3.66% |
| 2010 | -0.99 | 5.65 | 8.41 | -2.22 | -6.38 | -8.47 | -1.19 | -0.38 | 5.33 | 4.30 | 2.06 | 4.71 | +9.81% |
| 2011 | -3.47 | -0.75 | 5.01 | 3.77 | 1.15 | 1.03 | -4.44 | -7.46 | 2.25 | 3.55 | 1.20 | 6.44 | +7.60% |
| 2012 | 10.09 | 2.53 | 2.17 | 0.52 | 3.47 | 0.85 | 6.06 | -1.06 | 3.26 | -4.74 | 4.07 | -4.34 | +24.30% |
| 2013 | 10.36 | 4.19 | 8.01 | 6.76 | 7.49 | -4.71 | 14.55 | -2.40 | 2.16 | -0.14 | 5.45 | 0.20 | +63.65% |
| 2014 | 11.45 | 7.11 | -15.66 | -2.24 | 5.37 | 6.04 | 1.07 | 8.80 | 2.75 | 9.45 | 4.39 | 2.48 | +45.50% |
| 2015 | 9.68 | 2.51 | 6.34 | -5.46 | 8.69 | -4.65 | 4.94 | -6.67 | -15.65 | 9.59 | 6.28 | -1.37 | +11.16% |
| 2016 | -20.33 | 2.20 | -4.09 | 5.96 | -0.22 | -1.47 | 14.35 | -0.07 | 2.99 | -3.85 | 4.93 | -2.57 | -5.87% |
| 2017 | 0.45 | 8.19 | -1.36 | -1.62 | -4.63 | 8.24 | 2.24 | 2.54 | -0.79 | -3.41 | -4.76 | 4.19 | +8.55% |
| 2018 | 7.34 | -3.36 | -5.37 | 4.34 | 4.62 | -0.06 | 5.14 | 5.63 | -0.50 | -12.71 | 2.12 | -12.18 | -7.34% |
| 2019 | 12.78 | 5.50 | -2.63 | -0.55 | -3.49 | 3.97 | 2.87 | -5.21 | -6.97 | 2.68 | 10.45 | -0.64 | +18.15% |
| 2020 | -0.76 | -0.33 | 1.20 | 14.80 | 7.91 | 4.10 | -5.91 | -2.63 | 6.36 | -3.27 | 4.71 | 3.14 | +31.42% |
| 2021 | 1.77 | -2.95 | -5.29 | 4.49 | -5.85 | 9.57 | -1.35 | 8.11 | -1.49 | -2.80 | -1.80 | 1.22 | +2.35% |
| 2022 | -13.91 | -1.12 | 7.04 | -3.84 | -2.20 | 6.05 | 6.50 | 3.99 | 4.47 | 2.22 | -3.40 | -0.77 | +3.02% |
| 2023 | 1.52 | -3.15 | -2.54 | 2.28 | -1.12 | -2.34 | -0.58 | 1.04 | -0.45 | -7.13 | -0.27 | 15.32 | +1.09% |
| 2024 | 1.85 | 3.64 | -1.17 | -6.03 | 1.89 | 6.88 | 5.17 | -0.52 | -7.05 | 3.05 | 2.06 | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.11% | 16.30% | 17.01% | 20.99% | 22.85% |
| Sharpe ratio | 0.49 | 0.75 | 0.97 | 0.01 | 0.32 |
| Best month | +15.32% | +6.88% | +15.32% | +15.32% | +15.32% |
| Worst month | -7.05% | -7.05% | -7.05% | -13.91% | -13.91% |
| Maximum loss | -10.06% | -8.29% | -10.06% | -23.50% | -26.31% |
| Outperformance | +6.44% | - | +5.79% | -0.32% | +1.88% |
All quotes in GBP
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| AXA Framlington Biotech R Income... | paying dividend | 2.8290 | +19.42% | +10.08% | |
| AXA Framlington Biotech Fund R A... | reinvestment | 2.8280 | +19.48% | +10.04% |
Performance
| YTD | +9.19% | ||
|---|---|---|---|
| 6 Months | +7.45% | ||
| 1 Year | +19.48% | ||
| 3 Years | +10.04% | ||
| 5 Years | +64.13% | ||
| 10 Years | +106.57% | ||
| Since start | +496.75% | ||
| Year | |||
| 2023 | +1.09% | ||
| 2022 | +3.02% | ||
| 2021 | +2.35% | ||
| 2020 | +31.42% | ||
| 2019 | +18.15% | ||
| 2018 | -7.34% | ||
| 2017 | +8.55% | ||
| 2016 | -5.87% | ||
| 2015 | +11.16% | ||
